A Finlay1, G Wittert2, C E Short2. 1. The Freemasons Foundation Centre for Men's Health, School of Medicine, Level 7, South Australian Health and Medical Research Institute, University of Adelaide, Post Box 11060, Adelaide, 5001, SA, Australia. amy.finlay@adelaide.edu.au. 2. The Freemasons Foundation Centre for Men's Health, School of Medicine, Level 7, South Australian Health and Medical Research Institute, University of Adelaide, Post Box 11060, Adelaide, 5001, SA, Australia.
Abstract
PURPOSE: Men who are survivors of prostate cancer report a variety of psychological and physical factors contributing to a lower quality of life, and physical activity can assist to mitigate these issues. This review aims to provide a summary of physical activity behaviour change trials targeting prostate cancer survivors, assess the feasibility of these interventions and, if possible, identify intervention and study characteristics associated with significant intervention effects. METHOD: Four databases (PubMed, CINAHL, PsycINFO and EMBASE) were systematically searched for randomised controlled trials containing at least one behavioural outcome relating to physical activity published up until July 2016. Forward and backwards, hand, key author citation searching and known research were also considered. RESULTS: From a total of 13, 828 titles, the search resulted in 12 studies (6 prostate cancer only and 6 mixed cancer interventions), eight of which found positive results most often related immediately to post-intervention aerobic activity. Factors relating to efficacy were not conclusive due to the heterogeneity of studies and lack of cancer-specific data in mixed cancer trials. Future research focusing on intervention reach, maintenance of intervention effects and resistance training outcomes is needed. CONCLUSION: There is preliminary evidence to suggest that a variety of physical activity behaviour change interventions targeting men with a history of prostate cancer can be efficacious, at least in the short term. Experimental studies are required to identify key intervention features. IMPLICATIONS FOR CANCER SURVIVORS: Physical activity interventions can assist prostate cancer survivors in relation to short-term lifestyle change, though more evidence is required to improve the clarity of factors related to efficacy.
PURPOSE:Men who are survivors of prostate cancer report a variety of psychological and physical factors contributing to a lower quality of life, and physical activity can assist to mitigate these issues. This review aims to provide a summary of physical activity behaviour change trials targeting prostate cancer survivors, assess the feasibility of these interventions and, if possible, identify intervention and study characteristics associated with significant intervention effects. METHOD: Four databases (PubMed, CINAHL, PsycINFO and EMBASE) were systematically searched for randomised controlled trials containing at least one behavioural outcome relating to physical activity published up until July 2016. Forward and backwards, hand, key author citation searching and known research were also considered. RESULTS: From a total of 13, 828 titles, the search resulted in 12 studies (6 prostate cancer only and 6 mixed cancer interventions), eight of which found positive results most often related immediately to post-intervention aerobic activity. Factors relating to efficacy were not conclusive due to the heterogeneity of studies and lack of cancer-specific data in mixed cancer trials. Future research focusing on intervention reach, maintenance of intervention effects and resistance training outcomes is needed. CONCLUSION: There is preliminary evidence to suggest that a variety of physical activity behaviour change interventions targeting men with a history of prostate cancer can be efficacious, at least in the short term. Experimental studies are required to identify key intervention features. IMPLICATIONS FOR CANCER SURVIVORS: Physical activity interventions can assist prostate cancer survivors in relation to short-term lifestyle change, though more evidence is required to improve the clarity of factors related to efficacy.
Authors: P J Morgan; D R Lubans; R Callister; A D Okely; T L Burrows; R Fletcher; C E Collins Journal: Int J Obes (Lond) Date: 2010-08-10 Impact factor: 5.095
Authors: Kirsten N Adlard; David G Jenkins; Chloe E Salisbury; Kate A Bolam; Sjaan R Gomersall; Joanne F Aitken; Suzanne K Chambers; Jeff C Dunn; Kerry S Courneya; Tina L Skinner Journal: BMC Cancer Date: 2019-07-03 Impact factor: 4.430
Authors: Kerri M Winters-Stone; Stacey A Kenfield; Erin L Van Blarigan; Esther L Moe; Justin W Ramsdill; Kimi Daniel; Greta Macaire; Kellie Paich; Elizabeth R Kessler; Omer Kucuk; Theresa W Gillespie; Karen S Lyons; Tomasz M Beer; Jeanette M Broering; Peter R Carroll; June M Chan Journal: JMIR Res Protoc Date: 2018-11-15
Authors: June M Chan; Erin L Van Blarigan; Stacey A Kenfield; Kerri M Winters-Stone; Crystal S Langlais; Shoujun Zhao; Justin W Ramsdill; Kimi Daniel; Greta Macaire; Elizabeth Wang; Kellie Paich; Elizabeth R Kessler; Tomasz M Beer; Karen S Lyons; Jeanette M Broering; Peter R Carroll Journal: J Med Internet Res Date: 2020-12-31 Impact factor: 5.428
Authors: Sean F Mungovan; Sigrid V Carlsson; Gregory C Gass; Petra L Graham; Jaspreet S Sandhu; Oguz Akin; Peter T Scardino; James A Eastham; Manish I Patel Journal: Nat Rev Urol Date: 2021-04-08 Impact factor: 14.432
Authors: Linda Trinh; Catherine M Sabiston; Shabbir M H Alibhai; Jennifer M Jones; Kelly P Arbour-Nicitopoulos; Daniel Santa Mina; Kristin Campbell; Guy E Faulkner Journal: BMC Public Health Date: 2022-04-28 Impact factor: 4.135
Authors: Holly E L Evans; Cynthia C Forbes; Corneel Vandelanotte; Daniel A Galvão; Robert U Newton; Gary Wittert; Suzanne Chambers; Ganessan Kichenadasse; Nicholas Brook; Danielle Girard; Camille E Short Journal: Int J Behav Med Date: 2020-09-23
Authors: Erin L Van Blarigan; Stacey A Kenfield; Elizabeth Y Wang; Rebecca E Graff; June M Chan; Crystal S Langlais; Jeanette M Broering; Justin W Ramsdill; Elizabeth R Kessler; Kerri M Winters-Stone Journal: JMIR Cancer Date: 2020-11-10